A. "Expedited partner therapy" means to prescribe, administer, dispense, or otherwise provide antimicrobial drugs to a sexual partner of a patient clinically diagnosed by a health care provider as infected with a sexually transmitted infection without a physical examination of such sexual partner, shall not apply to any sexually transmitted infection that could be chronic or require multiple treatment courses.B.1. Subject to limitations provided by law or rule including but not limited to laws or rules governing scope of practice, supervision of health care providers, and delegation of health care services, a health care provider who clinically diagnosed a patient with a sexually transmitted infection may provide expedited partner therapy if, in the professional judgment of the health care provider, the patient's sexual partner is unlikely or unable to present for examination, testing, and treatment.2. A health care provider who provides expedited partner therapy shall provide counseling to the patient, including distributing written materials developed and provided by the State Department of Health to be given by the patient to the patient's sexual partner.3. A health care provider shall use expedited partner therapy only for a patient's sexual partner who may have been exposed to a sexually transmitted infection and who is able to be contacted and identified by the patient.C.1. No health care provider or pharmacist shall be liable for civil damages resulting from any act or omission in good-faith compliance with the provisions of this section, including civil damages for refusing to provide expedited partner therapy, other than an act or omission constituting gross negligence or willful or wanton misconduct.2. No health care provider or pharmacist shall be subject to disciplinary action by the provider's or pharmacist's licensing board on the basis of an act or omission in good-faith compliance with the provisions of this section, other than an act or omission constituting gross negligence or willful or wanton misconduct.D. The Department shall include the following information in written materials developed and provided for distribution as required by paragraph 2 of subsection B of this section:1. A warning that a woman who is pregnant or might be pregnant should not take certain antibiotics and should immediately contact a health care provider for an examination;2. Information about the antimicrobial drug and dosage provided or prescribed, including a warning that a sexual partner who has a history of allergy to the drug or the pharmaceutical class of drug should not take the drug and should immediately contact a health care provider for examination;3. Information about the treatment and prevention of sexually transmitted infections;4. The requirement of sexual abstinence until a period of time after treatment to prevent infecting other sexual partners;5. Notification of the importance of the sexual partners receiving examination and testing for human immunodeficiency virus and other sexually transmitted infections and information about available resources;6. Notification of the risk to the patient, the patient's sexual partner, and the general public if the sexually transmitted infection is not completely and successfully treated;7. The responsibility of the sexual partner to inform the sexual partner's own sexual partners of the risk of sexually transmitted infections and the importance of prompt examination and treatment by a health care provider; and8. Such other information deemed necessary by the State Commissioner of Health.E. The State Commissioner of Health, the State Board of Medical Licensure and Supervision, the State Board of Osteopathic Examiners, the Oklahoma Board of Nursing, and the State Board of Pharmacy may promulgate rules as necessary to implement this section.Okla. Stat. tit. 63, § 1-522.1
Added by Laws 2024 , c. 352, s. 1, eff. 11/1/2024.